All News
Role of of Guselkumab in improving fatigue!
Philip Mease @RheumNow #Rnl2022 https://t.co/G5mKzXsZNt
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Allodynia is pain due to a stimulus which does not normally provoke pain.
Hyperesthesia is an increased sensitivity to painful stimulation.
@Tuhina_Neogi @RheumNow #rnl2022 https://t.co/Rmn4YWX4kY
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
And last but not least! We are closing out RheumNow Live with POD 7: Rheumatoid arthritis – Best Management. Dr. Janet Pope will begin the pod with Drug Cycling Vs Switching in RA. #RNL2022 https://t.co/0LhxH9z2Ky
Dr. John Cush RheumNow ( View Tweet)
Fibromyalgia as a co morbid condition in Rheumatic disease.
Philip Mease @RheumNow #Rnl2022 https://t.co/gcWUoXeKhc
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Most chronic pain is as you would think, back pain and OA. Dr. @Tuhina_Neogi #RNL2022 @RheumNow https://t.co/0thMj6mzjp
Dr. Rachel Tate uptoTate ( View Tweet)
Dr. P Mease tackles the hard subject of pain and fatigue in rheum dz. He avoids the "F" word (#fibromyalgia) in favor of "Central Sensitization" that has less of a stigma. @rheumnow #RNL2022 https://t.co/QmpCxknUXm
TheDaoIndex KDAO2011 ( View Tweet)
Dr. Mease reviews fatigue measures in rheumatic disease. Do you use any of these if your practice? #RNL2022 @RheumNow https://t.co/LWR1kcgRHk
Dr. Rachel Tate uptoTate ( View Tweet)
"Ask patients what they can do/can't do rather than ask what is their pain level." - Dr. P Mease on how this question takes the focus off of #pain but redirects more towards function and what can be done. #RNL2022 @RheumNow
TheDaoIndex KDAO2011 ( View Tweet)
Dr. Mease reviews overlap in pain, fatigue, psychosocial state and disease activity. #RNL2022 @RheumNow https://t.co/0J9HWdZPpB
Dr. Rachel Tate uptoTate ( View Tweet)
Fibromyalgia is incredibly common in people with rheumatic diseases. Those with #fibromyalgia have higher measures of disease activity and are less likely to achieve remission. What are we doing about it? #RNL2022 by Dr Philip Mease https://t.co/k8D9Bvx6Lc
Jonathan Hausmann MD hausmannMD ( View Tweet)
Dr. @Tuhina_Neogi reminds us that chronic pain affects 1.52 billion people in the world! That's approximately 20% of the population! It costs approximately $635B annually! The better we understand it the better we will be able to treat it. #RNL2022 @RheumNow https://t.co/KE5sMZWqU9
Dr. Rachel Tate uptoTate ( View Tweet)
"Asking a dermatologist to discuss the whole psoriatic disease patient is a little like asking a dog to do a haiku." Dr. Merola discusses combined derm-rheum clinics and collaborative care models for best care of patients. #RNL2022 @RheumNow https://t.co/u5mhpZunnt
Dr. Rachel Tate uptoTate ( View Tweet)
Dr. Philip Mease on the importance of recognizing fibromyalgia, especially concurrently with rheumatic diseases
FM does impact disease severity, esp in RA and AS
@RheumNow #RNL2022 https://t.co/cGFYYdf6GU
Robert B Chao, MD doctorRBC ( View Tweet)
Dr. Tuhina Neon on rethinking pain and analgesia
Emerging pain targets nicely organized
@RheumNow #RNL2022 https://t.co/HqLMbcgF6N
Robert B Chao, MD doctorRBC ( View Tweet)
Do you discuss/screen for depression with your patients when discussing pain and fatigue? #RNL2022 @RheumNow
Dr. Rachel Tate uptoTate ( View Tweet)
🟢#ClinicalPearls #RheumTwitter #PsA #RNL2022
✅Axial Disease in PsA
@Official_ASAS @NPF @PsoriasisUK https://t.co/zgNUt5ndfi
debaditya_roy debaditya_roy ( View Tweet)
Dr. Jonathan Hausman on JIA
Most subjects equivalent to adult forms of inflammatory arthritis - note early onset seronegative oligoarthritis
Tips on transitioning to adult care - determine extent of active disease vs. chronic damage
@RheumNow #RNL2022 https://t.co/MhjH04PQ3e
Robert B Chao, MD doctorRBC ( View Tweet)
Only about 40% of JIA patients will be in remission off medications long-term so adult rheums will see these pts. Dr. @hausmannMD shared this great graphic. Note: 0 patients who presented as +RF polyarthritis patients were in remission off drug at 5 year f/u. #RNL2022 @RheumNow https://t.co/oPG2WbuuHW
Dr. Rachel Tate uptoTate ( View Tweet)
ILAR classifications vs the reality of disease changes seen in pedi clinics is an issue for continuing care. Dr. @hausmannMD reviews arthritis clusters which may make it easier to understand from an adult rheum perspective. #RNL2022 @RheumNow https://t.co/7xYD96R5Rw
Dr. Rachel Tate uptoTate ( View Tweet)
Transition programs improve health and QoL of pedi-to-adult rheumatology patients in addition to their autonomy/independence! Dr. @hausmannMD gives both pediatric and adult recommendations to ease care at #RNL2022 @RheumNow https://t.co/e5erQ5nkcE
Dr. Rachel Tate uptoTate ( View Tweet)